<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: A rare but significant cause for <z:hpo ids='HP_0001297'>stroke</z:hpo> is sub-intimal carotid dissection and this mechanism accounts for approximately 2.5% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0001297'>strokes</z:hpo>.(1) Dissection of the carotid artery is often caused by trauma to the face or neck.(2) Under 45 years old, it is the second leading cause of <z:hpo ids='HP_0001297'>stroke</z:hpo>.(3) Neurological symptoms can be lacking or subtle, therefore the condition may be overlooked but the pathological processed is believed to be attributed to <z:hpo ids='HP_0001907'>thromboembolism</z:hpo>.(4) Microemboli in the middle cerebral artery, are known as a risk factor for ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> following a <z:e sem="disease" ids="C0007787" disease_type="Disease or Syndrome" abbrv="tia|TIA|T.I.A.">transient ischaemic attack</z:e> (<z:hpo ids='HP_0002326'>TIA</z:hpo>) and can be detected by transcranial Doppler examination (TCD).(5) The established treatment regime is antiplatelet therapy, anticoagulation or both along with supportive therapy.(6) Current evidence suggests managing microemboli in both crescendo <z:hpo ids='HP_0002326'>TIA</z:hpo>'s and post carotid endarterectomy improves outcome.(7) We have found the use of <z:chebi fb="0" ids="9605">Tirofiban</z:chebi>, a potent intravenous antiplatelet agent currently licensed for use in <z:hpo ids='HP_0011009'>acute</z:hpo> coronary syndrome, effective in the treatment of microemboli in this manner.(7) CASE PRESENTATION: We report a case of symptomatic <z:e sem="disease" ids="C0338585" disease_type="Disease or Syndrome" abbrv="">carotid artery dissection</z:e> post radical neck dissection, causing TCD detected microemboli and successfully treated with <z:chebi fb="0" ids="9605">Tirofiban</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>CONCLUSION: We believe further study into the use of <z:chebi fb="0" ids="9605">Tirofiban</z:chebi> in the treatment of microemboli after carotid dissection is indicated </plain></SENT>
</text></document>